Maryland will expand Phase 1 eligibility for some immunocompromised Marylanders starting next week. The new groups added to Phase 1 starting February 1 include cancer patients in active treatment, end-stage renal disease requiring hemodialysis, chronic obstructive pulmonary disease, solid organ transplant patients–recipients– and those with sickle cell disease and diabetes. They will be able to get the vaccine through their hospital-based providers. Dr. David Marcozzi said this decision comes after consulting with University of Maryland Medical System and Johns Hopkins.
Maryland Expands Phase 1 COVID Vaccine Eligibility For Severely Immunocompromised Marylanders
January 27, 2021